MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
ETON — Eton Pharmaceutcials, Inc. Common Stock
NasdaqEton Pharmaceutcials, Inc. Common Stock
$55.36
+3.38(+6.50%)
- O
- 52.42
- H
- 56.00
- L
- 52.00
- V
- 673K
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About ETON
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateNov 14, 2018
Employees44
Stock ExchangeNasdaq
Ticker SymbolETON
Websitehttps://www.etonpharma.com
Key Financial Statistics
| Market Cap | $1.58B |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $14.27 - $66.37 |
| 52-Week Avg Volume | 401.2K |
| VWAP | $54.71 |
| Transactions | 12,835 |
| Total Recorded Bars | 1,981 days |